CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The ClearRing system offers a minimally invasive solution for treating Benign Prostatic Hyperplasia (BPH) by expanding the prostate to alleviate symptoms. This device aims to reduce costs and side effects compared to traditional treatments, allowing patients to return to normal activities more quickly.
There are approximately 30 million men worldwide who experience moderate to severe Benign Prostatic Hyperplasia (BPH) symptoms.
These symptoms, such as urgent need to urinate, difficulty starting urination, weak stream, or increased frequency of urination, are severe enough to disrupt a patient’s daily lifestyle.
Of the 30 million sufferers, an estimated 25% require immediate active treatment.
Transurethral Resection of the Prostate (TURP), the current gold standard procedure, is costly, ineffec…
PROARC MEDICAL LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
